Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Assessing Claims of Cannabis as an Anti-cancer Agent (CATA) — Stella

Home/Cancer/Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)

View on ClinicalTrials.gov

Recruiting

Back to Cancer trials

Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)

Trial locations(1 site)

United States

HealthPartners Institute Cancer Research Center, Saint Louis Park, Minnesota

Key details

Sponsor

HealthPartners Institute

Enrollment target

~50 participants

Started

March 2021

Primary completion

January 2027

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.